BioPacificVentures seeks to invest in life science companies which have, or are able to develop, the following characteristics:

• An Australasian presence or connection
• A sound business model with the potential for international growth
• A sustainable competitive advantage
• Exceptional technology or science with strong intellectual property
• An experienced management team, or a willingness to expand the management team to achieve growth

BioPacificVentures will invest broadly in all life science applications (medical, veterinary, nutrition and agbiotech) but with an emphasis on New Zealand’s and Australia’s key advantages:

• Prevention/Nutrition - functional and medical foods, dietary supplements, naturally derived bioactives, cosmeceuticals, skin care, anti-ageing therapies
• Green Biotech/Agbiotech - plant and animal health, sustainability and productivity, reproduction and growth, genetic traits
• Commercial Applications - Food and pharma processes, distribution, commercial tools, consumer relation management, novel packaging technologies, food safety
• Diagnostic and Medical devices - safety, quality control, analysis, medical devices, health and health services
• Therapeutics - pharmaceuticals, ophthalmologic products, small molecules, proteins, peptides, antibodies, plant extracts, vaccines, drug delivery technologies

BioPacificVentures' particular focus is on opportunities in the emerging "wellness through prevention" market, reflecting the increasing trend in healthcare towards the prevention, rather than the treatment, of chronic diseases. Opportunities of particular interest include functional and medical foods, nutraceuticals, cosmeceuticals, skin care, dietary supplements, infant and sports nutrition, immune stimulation and anti-aging therapies.